ADO 4.76% 2.0¢ anteotech ltd

Ann: Life Science Update, page-52

  1. 1,820 Posts.
    lightbulb Created with Sketch. 435
    If nothing has changed there wouldn’t be an announcement!
    The Indian update does ‘seem’ a little different as they’re testing symptomatic people with both nasal and saliva swabs, to me that’s a huge positive as it may bring the saliva test to market quicker if accuracy is verified against nasal swabs.
    If regulatory approval does take a month longer due to forces beyond ADO’s control; I can wait.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
-0.001(4.76%)
Mkt cap ! $51.84M
Open High Low Value Volume
2.1¢ 2.1¢ 2.0¢ $6.925K 330.2K

Buyers (Bids)

No. Vol. Price($)
8 1353492 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 380181 2
View Market Depth
Last trade - 15.23pm 23/08/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.